Squawk on the Street

Kicking off a holiday-shortened week for the markets, Jim Cramer and David Faber highlighted the latest vaccine news to lift stocks: AstraZeneca announced that its COVID-19 vaccine being developed in conjunction with Oxford University was up to 90 percent effective with no serious side effects in a clinical trial. The anchors explored the push to develop and execute a game plan to distribute vacci...

Jim Cramer and David Faber interviewed Treasury Secretary Steven Mnuchin about his decision to allow several of the Fed’s emergency lending programs to expire on December 31. They also discussed everything from the nationwide spike in COVID-19 cases and its impact on the economy to the status of stimulus talks with Speaker Pelosi. Dr. Monclef Slaoui -- the chief advisor for the government's "Opera...

Carl Quintanilla, Jim Cramer and David Faber discussed the Dow and S&P 500 extending Wednesday's losses on worries about COVID-19, with deaths surpassing 250,000 in the U.S. -- and the recent surge in cases resulting in lockdowns. The anchors also took a closer look at a push by business leaders and industry groups urging the White House to work with President-Elect Biden's transition team despite...

With the Dow looking to reach the 30,000 mark, Carl Quintanilla, Jim Cramer and David Faber discussed big news involving Boeing: The FAA approved the return of the company's long-grounded 737 MAX jet to service. They explored what this decision means for Boeing as well the airlines that have been struggling due to the pandemic. Also in focus: Retail earnings from the likes of Target and Lowe's ahe...

Carl Quintanilla, Jim Cramer and David Faber discuss Amazon’s latest move into the pharmacy space, offering online prescription fulfillment & free delivery for Prime members. The launch of Amazon Pharmacy pressuring shares of traditional drug store retailers like Walgreens (WBA) & CVS Health (CVS) Rite Aid (RAD), as well as pharmacy start-ups like GoodRX (GDRX). Plus, watching retail and the COVID...

Carl Quintanilla, Jim Cramer and David Faber discussed a big start to the week for the markets: The Dow and S&P 500 rally after drug maker Moderna announced that preliminary analysis of a phase 3 trial showed its experimental COVID-19 vaccine had an efficacy rate of 94.5-percent and saw no significant safety concerns. The Moderna news putting the Dow closer to hitting the 30,000 mark for the first...

Carl Quintanilla and Jim Cramer discussed how stocks are rebounding after Thursday’s sell-off. The anchors spoke about market reaction to NBC News and other news outlets calling Arizona for President-Elect Joe Biden. They also highlighted the importance of drug makers providing guidance as to when COVID-19 vaccines and treatments might become available to the public. One of the top stories: Disney...

Carl Quintanilla, Jim Cramer and David Faber discussed the big spike in COVID-19 cases putting pressure on the Dow and S&P 500. The anchors explored everything from how soon vaccines might become available to complacency among the public and where lockdowns could come into play. Also in focus: Airline stocks under pressure after Southwest said it recently experienced a deceleration in improving re...

Carl Quintanilla, Jim Cramer and David Faber discussed the road ahead for stocks and whether they can maintain their upward momentum. The anchors reacted to a new note from Goldman Sachs Chief U.S. Equity Strategist David Kostin, who is raising his year-end S&P 500 price target to 3,700. They also explored buying strategies when it comes to value versus growth and where COVID-19 and vaccines come...

Carl Quintanilla, Jim Cramer and David Faber discussed what's ahead for stocks one day after the Dow, S&P 500 and Nasdaq each surged to record intraday highs. They explored the concept of buying value and selling growth -- and which stocks went from "cheap to overvalued" during Monday's rally. The anchors also reacted to what Eli Lilly CEO David Ricks told CNBC after the FDA authorized the company...

On the first trading day since Joe Biden was declared President-Elect, Carl Quintanilla, Jim Cramer and David Faber discussed a record-setting day for stocks. The Dow and S&P 500 each soaring to all-time intraday highs in reaction to Pfizer and BioNTech announcing that their COVID-19 vaccine candidate was found to be more than 90-percent effective in participants who were not previously infected....

The opening hour of CNBC’s "Squawk on the Street" with Carl Quintanilla, Jim Cramer and David Faber is broadcast each weekday from the floor of the New York Stock Exchange, on site at the opening bell with the up-to-the-minute news investors need to know and interviews with the most influential CEOs and greatest market minds. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for inform...

The opening hour of CNBC’s "Squawk on the Street" with Carl Quintanilla, Jim Cramer and David Faber is broadcast each weekday from the floor of the New York Stock Exchange, on site at the opening bell with the up-to-the-minute news investors need to know and interviews with the most influential CEOs and greatest market minds. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for inform...

Carl Quintanilla, Jim Cramer and David Faber were all over the stock market's rally in reaction to Tuesday night's election results, which showed that neither President Trump nor his Democratic rival Joe Biden had secured enough electoral votes to win the presidency -- and that ballot counting would continue in several battleground states. The anchors explored what the presidential and congression...

Throughout the hour, Carl Quintanilla, Jim Cramer and David Faber discussed an Election Day surge for stocks, as investors bet on a presidential election victory for Joe Biden and Democratic control of both houses of Congress -- hoping such an outcome would make passage of a generous stimulus package more likely. As fort the rise in coronavirus, Carl, Jim and David reacted to former FDA Commission...

As we begin a new trading month, Carl Quintanilla, Jim Cramer and David Faber discussed a big rebound for stocks after the worst week for the markets since March. The anchors explored what impact Tuesday night's presidential election could have on certain sectors from healthcare to banking. The surge in coronavirus cases also in the spotlight after UK Prime Minster Boris Johnson announced over the...

Carl Quintanilla, Jim Cramer and David Faber discussed a rough October for stocks with the Dow on pace for its worst monthly performance since March. Thursday’s earnings reports from big tech companies such as Apple, Amazon, Facebook dragging down the markets, with election uncertainty and a spike in coronavirus cases also weighing on investor sentiment. The anchors also reacted to quarterly resul...

With stocks coming off their worst day since June, Carl Quintanilla, Jim Cramer and David Faber looked at what's ahead for the markets after Wednesday's big sell-off, with rising coronavirus cases and next week's presidential election on investors' radar. On the earnings front: The CEO Yum Brands -- The parent of KFC, Taco Bell and Pizza Hut -- discussed the company's better-than-expected quarterl...

Carl Quintanilla, Jim Cramer and David Faber offer analysis of Wednesday's sell-off on Wall Street, with a surge in coronavirus cases pressuring stocks and adding to uncertainty about an economic recovery. Another big earnings day as well: Boeing CEO David Calhoun and General Electric Chairman and CEO Larry Culp join the program to discuss their companies' quarterly results. Big tech also in focus...

Carl Quintanilla, Jim Cramer and David Faber led off the show by drilling down on the deal of the day: AMD agreeing to acquire rival chip maker Xilinx for $35-billion in stock. They spoke exclusively with AMD CEO Lisa Su, who explained how the deal fits into the company's growth strategy and will help it generate scale versus its competitors. A busy earnings calendar also in focus this morning, le...

Carl Quintanilla, Jim Cramer and David Faber took a closer look at a rough morning for stocks: Worries on Wall Street about rising coronavirus cases around the globe and a continued stalemate in the U.S. surrounding stimulus talks. Among the big movers: German software company SAP tumbles on weaker-than-expected quarterly results and full-year guidance, hurt by lockdowns due to the pandemic. As fo...

Carl Quintanilla, Jim Cramer and David Faber explored a number of issues on Wall Street's radar: The second and final presidential debate of the 2020 election - including reaction to President Trump's vaccine timeline, Gilead shares rising after its antiviral remdesivir became the first drug to receive FDA approval for treatment of COVID-19, and Intel shares tumbling after weakness in the chip mak...

Carl Quintanilla, Jim Cramer and David Faber discussed a big morning on the earnings front, including Tesla reporting a fifth consecutive quarterly profit and AT&T posting better-than-expected revenue, helped by stronger wireless growth and subscriber numbers for HBO and HBO Max. The CEOs of Southwest Airlines, Dow Inc. and Whirlpool appeared on the program to discuss their quarterly results and h...

Carl Quintanilla, Jim Cramer and David Faber led off with a look at tech earnings, with shares of Snapchat parent Snap Inc. soaring on a surprise quarterly profit, as well as stronger-than-expected revenue and user growth. A different story for Netflix: Shares slumping on weaker-than expected subscriber growth and its worst earnings miss in the company's history. The anchors also reacted to what S...

Carl Quintanilla, Jim Cramer and David Faber led off with an in-depth discussion about the Department of Justice filing an antitrust lawsuit against Google -- what this could mean for the company, shares of Alphabet and regulating big tech. The anchors also focused on the markets rising on hopes Speaker Pelosi and the White House will reach a deal on a stimulus package with hours to go before the...